American Trust’s Accendra Health ACH Stock Holding History

American Trust’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,724	Closed	-$211K	–	457
2022 Q2	$211K	Buy	6,724 +11	+0.2%	+$398	0.02%	411
2022 Q1	$296K	Buy	+6,713	New	+$288K	0.02%	354

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Trust's ACH Position: Q3 2022 in Review

American Trust sold out of Accendra Health (ACH) in Q3 2022, closing a stake of 6,724 shares — an estimated $211K sold.

American Trust first reported a position in ACH in Q1 2022 and held it in 2 quarters. The position peaked at $296K in Q1 2022. 227 funds tracked by Wall St. Rank hold ACH as of Q3 2022.

American Trust reported no remaining Accendra Health position as of Q3 2022 after selling out during the quarter.
American Trust sold 6,724 Accendra Health shares in Q3 2022, an estimated $211K.
American Trust first reported a position in Accendra Health in Q1 2022 and held it in 2 quarters.
American Trust's Accendra Health position peaked at $296K in Q1 2022.
227 funds tracked by Wall St. Rank held Accendra Health as of Q3 2022.

Based on American Trust's 13F filing for Q3 2022, filed 2 Dec 2022.